Cm. Boney et al., The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes, MOL ENDOCR, 14(6), 2000, pp. 805-813
Insulin-like growth factor-I (IGF-I) stimulates mitogenesis in proliferatin
g preadipocytes, but when cells reach confluence and become growth arrested
, IGF-I stimulates differentiation into adipocytes. IGF-I induces signaling
pathways that involve IGF-I receptor-mediated tyrosine phosphorylation of
Shc and insulin receptor substrate 1 (IRS-1). Either of these adaptor prote
ins can lead to activation of the three-kinase cascade ending in activation
of the extracellular signal-regulated kinase 1 and -2 (ERK-1 and -2) mitog
en-activated protein kinases (MAPKs). Several lines of evidence suggest tha
t activation of MAPK inhibits 3T3-L1 preadipocyte differentiation. We have
shown that IGF-I stimulation of MAPK activity is lost as 3T3-L1 preadipocyt
es begin to differentiate. This change in MAPK signaling coincides with los
s of IGF-I-mediated Shc, but not IRS-1, tyrosine phosphorylation. We hypoth
esized that downregulation of MARK via loss of proximal signaling through S
hc is an early component in the IGF-I switch from mitogenesis to differenti
ation in 3T3-L1 preadipocytes. Treatment of subconfluent cells with the MEK
inhibitor PD098059 inhibited both IGF-I-activation of MARK as well as H-3-
thymidine incorporation. PD098059, in the presence of differentiation-induc
ing media, accelerated differentiation in subconfluent cells as measured by
expression of adipocyte protein-2 (aP-2), peroxisome proliferator-activate
d receptor gamma (PPAR gamma) and lipoprotein lipase (LPL). Transient trans
fection of subconfluent cells with Shc-Y317F, a dominant-negative mutant, a
ttenuated IGF-I-mediated MAPK activation, inhibited DNA synthesis, and acce
lerated expression of differentiation markers aP-2, PPAR gamma, and LPL. We
conclude that signaling through Shc to MARK plays a critical role in media
ting IGF-I-stimulated 3T3-L1 mitogenesis. Our results suggest that loss of
the ability of IGF-I to activate Shc signaling to MARK may be an early comp
onent of adipogenesis in 3T3-L1 cells.